Table 4. IC₅₀ Values of TJ08 against Various Cancer Cells and Normal Cells^a.

	IC50 (μM)
compd	Jurkat	K562	MOLT-4	HeLa	HCT116	MIA-PaCa-2	HEK
TJ08	1.88 ± 0.51	1.89 ± 0.55	2.05 ± 0.72	2.11 ± 0.62	3.04 ± 0.8	3.82 ± 0.25	>50
DOXO	4.89 ± 0.11	0.99 ± 0.21	>1	0.21 ± 0.13	0.26 ± 0.19	0.059 ± 0.63	>50

^aMTT assay, cell treated with TJ08 and incubated for 48 h. IC₅₀ (μM) (mean ± SD, n = 3).